One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
Jan 14, 2013
0
0
Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.
Nov 1, 2012
0
0
In a new study, scientists at the University of Copenhagen show that a specific type of carbohydrate plays an important role in the intercellular signalling that controls the growth and development of the nervous system. ...
Apr 27, 2012
0
0
(Medical Xpress) -- Promising efforts to improve detection of early-stage kidney disease and treat children with neurofibromatosis have earned grants for Arizona State University research projects from the American Heart ...
Feb 22, 2012
0
0
(Medical Xpress) -- Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder.
Oct 14, 2011
0
0
Researchers at Children's National Medical Center have found that a cholesterol-lowering statin drug appears to be safe in children with neurofibromatosis type 1 (NF1) and may improve learning disabilities, including verbal ...
Sep 27, 2011
0
1
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings ...
Sep 12, 2011
0
0
